This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmad, A. Articles by Hart, I. Search for Related Content PubMed PubMed Citation Articles by Ahmad, A. Articles by Hart, I.

American Journal of Pathology, Vol 152, 721-728, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression

A Ahmad, A Hanby, E Dublin, R Poulsom, P Smith, D Barnes, R Rubens, P Anglard and I Hart
Richard Dimbleby Department of Cancer Research/ICRF, The Rayne Institute, St. Thomas' Hospital, London, United Kingdom.

Stromelysin 3 (ST3) is a matrix metalloproteinase implicated in mammary carcinoma progression. To date, localization of ST3 expression in breast cancer by in situ hybridization and immunocytochemistry has shown that the expression of the enzyme is limited to only the stromal fibroblasts surrounding the cancer cells. We have immunostained a large group of ductal carcinoma in situ and invasive breast carcinomas using a monoclonal antibody (5ST-4A9) raised against the hemopexin-like domain of human ST3. We show that invasive lobular carcinomas express significantly less ST3 than invasive ductal carcinomas (IDCs) (P = 0.002). We also show, for the first time, that certain breast carcinoma cells that have undergone a degree of epithelial-to-mesenchymal transition, the so-called metaplastic carcinomas, can express ST3 mRNA and protein, which may in part explain the increased metastatic propensity seen in a number of these tumors. In addition, patients with IDC who had moderate to strong ST3 levels had significantly shorter disease-free survival than those with negative or weak ST3 levels (P = 0.02). Furthermore, in node-positive IDC patients, multivariate analysis revealed that ST3 level was a strong, independent prognostic parameter for disease-free survival (P = 0.005).

This article has been cited by other articles:

				E. W. Thompson, D. F. Newgreen, and D. Tarin Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition? Cancer Res., July 15, 2005; 65(14): 5991 - 5995. [Full Text] [PDF]

				S. Arora, J. Kaur, C. Sharma, M. Mathur, S. Bahadur, N. K. Shukla, S. V.S. Deo, and R. Ralhan Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis Clin. Cancer Res., March 15, 2005; 11(6): 2272 - 2284. [Abstract] [Full Text] [PDF]

				V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al. Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958. [Abstract] [Full Text] [PDF]

				L. E. Jones, M. J. Humphreys, F. Campbell, J. P. Neoptolemos, and M. T. Boyd Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival Clin. Cancer Res., April 15, 2004; 10(8): 2832 - 2845. [Abstract] [Full Text] [PDF]

				W. Pan, M. Arnone, M. Kendall, R. H. Grafstrom, S. P. Seitz, Z. R. Wasserman, and C. F. Albright Identification of Peptide Substrates for Human MMP-11 (Stromelysin-3) Using Phage Display J. Biol. Chem., July 18, 2003; 278(30): 27820 - 27827. [Abstract] [Full Text] [PDF]

				J.-M. Su, Y.-Q. Wei, L. Tian, X. Zhao, L. Yang, Q.-M. He, Y. Wang, Y. Lu, Y. Wu, F. Liu, et al. Active Immunogene Therapy of Cancer with Vaccine On the Basis of Chicken Homologous Matrix Metalloproteinase-2 Cancer Res., February 1, 2003; 63(3): 600 - 607. [Abstract] [Full Text] [PDF]

				O. W. Petersen, H. L. Nielsen, T. Gudjonsson, R. Villadsen, F. Rank, E. Niebuhr, M. J. Bissell, and L. Ronnov-Jessen Epithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma Am. J. Pathol., February 1, 2003; 162(2): 391 - 402. [Abstract] [Full Text] [PDF]

				D. Luo, B. Mari, I. Stoll, and P. Anglard Alternative Splicing and Promoter Usage Generates an Intracellular Stromelysin 3 Isoform Directly Translated as an Active Matrix Metalloproteinase J. Biol. Chem., July 5, 2002; 277(28): 25527 - 25536. [Abstract] [Full Text] [PDF]

				R. Hoekstra, F.A.L.M. Eskens, and J. Verweij Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives Oncologist, October 1, 2001; 6(5): 415 - 427. [Abstract] [Full Text] [PDF]

				E. Dublin, A. Hanby, N. K. Patel, R. Liebman, and D. Barnes Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma : Fibroblastic Expression Has Strong Associations with Tumor Pathology Am. J. Pathol., October 1, 2000; 157(4): 1219 - 1227. [Abstract] [Full Text] [PDF]

				C S SETHI, T A BAILEY, P J LUTHERT, and N H V CHONG Matrix metalloproteinase biology applied to vitreoretinal disorders Br. J. Ophthalmol., June 1, 2000; 84(6): 654 - 666. [Full Text]

				A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian Matrix Metalloproteinases: Biologic Activity and Clinical Implications J. Clin. Oncol., March 1, 2000; 18(5): 1135 - 1135. [Abstract] [Full Text] [PDF]

				T. J. Delebecq, H. Porte, F. Zerimech, M.-C. Copin, V. Gouyer, E. Dacquembronne, M. Balduyck, A. Wurtz, and G. Huet Overexpression Level of Stromelysin 3 Is Related to the Lymph Node Involvement in Non-small Cell Lung Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1086 - 1092. [Abstract] [Full Text]

				D. Luo, E. Guerin, M.-G. Ludwig, I. Stoll, P. Basset, and P. Anglard Transcriptional Induction of Stromelysin-3 in Mesodermal Cells Is Mediated by an Upstream CCAAT/Enhancer-binding Protein Element Associated with a DNase I-hypersensitive Site J. Biol. Chem., December 24, 1999; 274(52): 37177 - 37185. [Abstract] [Full Text] [PDF]

				H. Kataoka, H. Uchino, T. Iwamura, M. Seiki, K. Nabeshima, and M. Koono Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of {alpha}1-Proteinase Inhibitor Generated by Matrix Metalloproteinases : A Possible Modulatory Role in Natural Killer Cytotoxicity Am. J. Pathol., February 1, 1999; 154(2): 457 - 468. [Abstract] [Full Text] [PDF]

				M.-G. Ludwig, P. Basset, and P. Anglard Multiple Regulatory Elements in the Murine Stromelysin-3 Promoter. EVIDENCE FOR DIRECT CONTROL BY CCAAT/ENHANCER-BINDING PROTEIN beta AND THYROID AND RETINOID RECEPTORS J. Biol. Chem., December 15, 2000; 275(51): 39981 - 39990. [Abstract] [Full Text] [PDF]